Lung colloid adenocarcinoma

Summary

Lung colloid adenocarcinoma (MONDO:0027772) is a disease. A subtype of mucinous adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lung colloid adenocarcinoma
Mondo ID	MONDO:0027772
DOID	DOID:0080303, DOID:0080304
NCIT	C45512
UMLS	C1708776
MedGen	313370
GARD	0025501
Anatomy (UBERON)	UBERON:0002048
Is cancer (heuristic)	no

Also known as: lung colloid adenocarcinoma · lung mucinous cystadenocarcinoma · lung mucinous cystic tumor of borderline malignancy · lung mucinous cystic tumour of borderline malignancy

Data availability: 2 cell lines.

Disease family

This is a subtype of mucinous adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › mucinous adenocarcinoma › lung colloid adenocarcinoma

Related subtypes (16): breast mucinous carcinoma, extrahepatic bile duct mucinous adenocarcinoma, cervical mucinous adenocarcinoma, fallopian tube mucinous adenocarcinoma, endometrial mucinous adenocarcinoma, rectum mucinous adenocarcinoma, mucoepidermoid carcinoma, gallbladder mucinous adenocarcinoma, colloid carcinoma of the pancreas, colon mucinous adenocarcinoma, ovarian mucinous adenocarcinoma, mucinous cystadenocarcinoma, acinar prostate mucinous adenocarcinoma, mucinous gastric adenocarcinoma, mucinous pancreas adenocarcinoma, salivary gland mucinous adenocarcinoma

Subtypes (2): mucinous bronchioloalveolar adenocarcinoma, pulmonary mucoepidermoid carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.